Sign Up Today and Learn More About Syapse Stock
Invest in or calculate the value of your shares in Syapse or other pre-IPO companies through EquityZen's platform.
About Syapse Stock
Founded
2008
Headquarters
San Francisco, CA, US
Total Funding
69.6M
Industries
Software, Data and Analytics, Science and Engineering
Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.
Syapse Press Mentions
Stay in the know about the latest news on Syapse
N-Power Medicine Acquires Syapse
finsmes • Jan 14, 2025
Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com
businesswire • Jan 01, 2025
Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials
finance • Aug 03, 2024
Signal: FDA renews Syapse collaboration to use real-world data in oncology
clinicaltrialsarena • Feb 23, 2024
Syapse and FDA Extend Collaboration to Advance the Use of Real-World Data (RWD) and Inform Regulatory Science in Oncology
globenewswire • Dec 07, 2023
Investors in Syapse
Discover investors in Syapse stock and explore their portfolio companies
Syapse Management
Leadership team at Syapse
Chief Executive Officer
Ken Tarkoff
Chief Financial Officer
Fletcher Payne
Join now and verify your accreditation status to gain access to:
- Syapse Current Valuation
- Syapse Stock Price
- Syapse Management
- Available deals in Syapse and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Syapse Cap Table and Funding History by Share Class and Liquidity Preferences
- Syapse Revenue and Financials
- Syapse Highlights
- Syapse Business Model
- Syapse Risk Factors
- Syapse Research Report from SACRA Research
Trading Syapse Stock
How to invest in Syapse stock?
Accredited investors can buy pre-IPO stock in companies like Syapse through EquityZen funds. These investments are made available by existing Syapse shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Syapse stock?
Shareholders can sell their Syapse stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
